Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Avo In R/R And Previously Untreated MCL

NCT04855695

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

NCT06333262

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • New England Cancer Specialists Scarborough, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

NCT04223765

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

NCT05366881

Conditions
Adnexal Diseases, Bladder Cancer, Blood Protein Disorders, +96 more
Locations
  • City of Hope Duarte, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • North Georgia Health System Gainesville, Georgia, United States
  • Baptist Floyd New Albany, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT05512390

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +21 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 247752 Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232 Miami, Florida, United States
  • Allina Health System /ID# 251782 Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center /ID# 246715 Omaha, Nebraska, United States
View all 20 locations
View Trial Details

Related conditions